Back to search
Autosomal Dominant Retinitis Pigmentosa
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Autosomal Dominant Retinitis Pigmentosa trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Autosomal Dominant Retinitis Pigmentosa trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…
This integrated Ph1/2 clinical study is to assess the safety, tolerability and pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of OCT-980 in healthy v…
The aim of the study is to apply a novel clinical investigation protocol in patients with Phosphodiesterase 6A (PDE6A), PDE6B and Rhodopsin (RHO)-based retiniti…